Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a portfolio-based biotechnology company focused on the development of technologies that have the potential to make a medical or commercial impact. The Company is focused on the clinical development of its drug platform in targeting dipeptidase-1 (DPEP-1) mediated organ inflammation in the lungs, liver and kidneys. Its lead drug candidate is LSALT Peptide (Metablok). LSALT Peptide is developed for targeting organ inflammation often experienced in hospitalized COVID-19 patients. It focuses on therapeutic development of LSALT Peptide and other DPEP-1 targeting drug candidates for new indications where inflammation of the lungs, liver and kidneys is an unmet problem. It has additional technology platforms in its portfolio including AB569, which focuses on preventing antibiotic resistant bacterial infections; Borg, which is a peptide-solid surface interface, and MetaMx, which is a synthetic molecule that target brain tumor initiating cells and invasive glioma cells.


TSXV:ARCH - Post by User

Post by Riverfolkon Nov 02, 2021 4:23pm
102 Views
Post# 34079176

New All Time High - Above 50 day average volume

New All Time High - Above 50 day average volume
House Positions for C:ARCH from 20211102 to 20211102
House Bought $Val Ave Sold $Val Ave Net $Net
22 Fidelity 25,300 74,920 2.961 0   25,300 -74,920
79 CIBC 6,500 19,091 2.937 2,705 8,207 3.034 3,795 -10,884
13 Instinet 2,000 5,840 2.92 0   2,000 -5,840
85 Scotia 1,619 5,035 3.11 0   1,619 -5,035
124 Questrade 1,592 4,826 3.031 0   1,592 -4,826
2 RBC 1,300 3,812 2.932 760 2,219 2.92 540 -1,593
68 Leede 399 1,175 2.945 319 947 2.969 80 -228
14 ITG 158 460 2.911 136 402 2.956 22 -58
53 Morgan Stanley 0   64 183 2.859 -64 183
83 Mackie 0   250 764 3.056 -250 764
9 BMO Nesbitt 2,000 5,840 2.92 5,000 15,470 3.094 -3,000 9,630
80 National Bank 477 1,401 2.937 5,116 14,954 2.923 -4,639 13,553
7 TD Sec 19,095 56,396 2.953 30,490 88,980 2.918 -11,395 32,584
1 Anonymous 66,300 191,112 2.883 81,900 237,781 2.903 -15,600 46,669
TOTAL 126,740 369,908 2.919 126,740 369,907 2.919 0 -1

<< Previous
Bullboard Posts
Next >>